1. Boehringer Ingelheim Kg (17 from 197 patents)

2. Boehringer Ingelheim Pharma Kg (7 from 149 patents)

3. Boehringer Ingelheim Gmbh (5 from 306 patents)

4. Boehringer Ingelheim Pharma Gmbh & Co Kg (5 from 194 patents)

5. Boehringer Ingelheim Vetmedica Gmbh (2 from 306 patents)

6. Dr. Karl Thomae Gmbh (1 from 133 patents)

7. Karl Thomae Gmbh (1 from 36 patents)

8. C. H. Boehringer Sohn (1 from 9 patents)

1. 7084140 - Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds

2. 7019021 - Compounds and methods for treating urinary incontinence

3. 6858594 - Compounds and methods for treating urinary incontinence

4. 6747044 - Neurokinin antagonists

5. 6747051 - m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

6. 6703409 - 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug

7. 6664253 - Neurokinin antagonists

8. 6660772 - Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence

9. 6602897 - m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

10. 6498162 - Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds

11. 6413959 - Method of treating depression with arylglycinamide derivatives

12. 6303601 - Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds

13. 6294556 - Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds

14. 6277840 - Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds

15. 6268389 - Treatment of urinary incontinence by administration of &agr;1L-adrenoceptor agonists